FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W611330989> ?p ?o ?g. }

• W611330989 endingPage "181" @default.
• W611330989 startingPage "135" @default.
• W611330989 abstract "Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid, pancreas, pituitary, adrenal). Because effective treatments have been developed for the hormone excess state, which was a major cause of death in these patients in the past, coupled with the recognition that nonendocrine tumors increasingly develop late in the disease course, the natural history of the disease has changed. An understanding of the current causes of death is important to tailor treatment for these patients and to help identify prognostic factors; however, it is generally lacking.To add to our understanding, we conducted a detailed analysis of the causes of death and prognostic factors from a prospective long-term National Institutes of Health (NIH) study of 106 MEN1 patients with pancreatic endocrine tumors with Zollinger-Ellison syndrome (MEN1/ZES patients) and compared our results to those from the pooled literature data of 227 patients with MEN1 with pancreatic endocrine tumors (MEN1/PET patients) reported in case reports or small series, and to 1386 patients reported in large MEN1 literature series. In the NIH series over a mean follow-up of 24.5 years, 24 (23%) patients died (14 MEN1-related and 10 non-MEN1-related deaths). Comparing the causes of death with the results from the 227 patients in the pooled literature series, we found that no patients died of acute complications due to acid hypersecretion, and 8%-14% died of other hormone excess causes, which is similar to the results in 10 large MEN1 literature series published since 1995. In the 2 series (the NIH and pooled literature series), two-thirds of patients died from an MEN1-related cause and one-third from a non-MEN1-related cause, which agrees with the mean values reported in 10 large MEN1 series in the literature, although in the literature the causes of death varied widely. In the NIH and pooled literature series, the main causes of MEN1-related deaths were due to the malignant nature of the PETs, followed by the malignant nature of thymic carcinoid tumors. These results differ from the results of a number of the literature series, especially those reported before the 1990s. The causes of non-MEN1-related death for the 2 series, in decreasing frequency, were cardiovascular disease, other nonendocrine tumors > lung diseases, cerebrovascular diseases. The most frequent non-MEN1-related tumor deaths were colorectal, renal > lung > breast, oropharyngeal. Although both overall and disease-related survival are better than in the past (30-yr survival of NIH series: 82% overall, 88% disease-related), the mean age at death was 55 years, which is younger than expected for the general population.Detailed analysis of causes of death correlated with clinical, laboratory, and tumor characteristics of patients in the 2 series allowed identification of a number of prognostic factors. Poor prognostic factors included higher fasting gastrin levels, presence of other functional hormonal syndromes, need for >3 parathyroidectomies, presence of liver metastases or distant metastases, aggressive PET growth, large PETs, or the development of new lesions.The results of this study have helped define the causes of death of MEN1 patients at present, and have enabled us to identify a number of prognostic factors that should be helpful in tailoring treatment for these patients for both short- and long-term management, as well as in directing research efforts to better define the natural history of the disease and the most important factors determining long-term survival at present." @default.
• W611330989 created "2016-06-24" @default.
• W611330989 creator A5005161415 @default.
• W611330989 creator A5036976011 @default.
• W611330989 creator A5045370897 @default.
• W611330989 creator A5069995013 @default.
• W611330989 creator A5085405229 @default.
• W611330989 date "2013-05-01" @default.
• W611330989 modified "2023-09-30" @default.
• W611330989 title "Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1" @default.
• W611330989 cites W103542863 @default.
• W611330989 cites W118005063 @default.
• W611330989 cites W1202324019 @default.
• W611330989 cites W128553046 @default.
• W611330989 cites W131086844 @default.
• W611330989 cites W1417635463 @default.
• W611330989 cites W148597247 @default.
• W611330989 cites W1489375199 @default.
• W611330989 cites W1492088446 @default.
• W611330989 cites W14922360 @default.
• W611330989 cites W1497912223 @default.
• W611330989 cites W1503265839 @default.
• W611330989 cites W1509748804 @default.
• W611330989 cites W1514440348 @default.
• W611330989 cites W1526715518 @default.
• W611330989 cites W1527733601 @default.
• W611330989 cites W1531121928 @default.
• W611330989 cites W1541830479 @default.
• W611330989 cites W1548099609 @default.
• W611330989 cites W1556397495 @default.
• W611330989 cites W156166223 @default.
• W611330989 cites W1570164955 @default.
• W611330989 cites W1595819497 @default.
• W611330989 cites W1599814620 @default.
• W611330989 cites W1615457766 @default.
• W611330989 cites W1642383825 @default.
• W611330989 cites W168727738 @default.
• W611330989 cites W1695950268 @default.
• W611330989 cites W1727274876 @default.
• W611330989 cites W177051930 @default.
• W611330989 cites W177749713 @default.
• W611330989 cites W1826218596 @default.
• W611330989 cites W182852221 @default.
• W611330989 cites W1831959306 @default.
• W611330989 cites W1836699425 @default.
• W611330989 cites W1856543148 @default.
• W611330989 cites W187803284 @default.
• W611330989 cites W1887272238 @default.
• W611330989 cites W1897600324 @default.
• W611330989 cites W1900522478 @default.
• W611330989 cites W1902680889 @default.
• W611330989 cites W1914636594 @default.
• W611330989 cites W1917620582 @default.
• W611330989 cites W1923168725 @default.
• W611330989 cites W1923737438 @default.
• W611330989 cites W1926760043 @default.
• W611330989 cites W1928540068 @default.
• W611330989 cites W1953717732 @default.
• W611330989 cites W1963524034 @default.
• W611330989 cites W1963847126 @default.
• W611330989 cites W1963972672 @default.
• W611330989 cites W1964153922 @default.
• W611330989 cites W1964184861 @default.
• W611330989 cites W1964586919 @default.
• W611330989 cites W1965235610 @default.
• W611330989 cites W1965242632 @default.
• W611330989 cites W1965669773 @default.
• W611330989 cites W1966472515 @default.
• W611330989 cites W1966679509 @default.
• W611330989 cites W1967316472 @default.
• W611330989 cites W1967907482 @default.
• W611330989 cites W1968200190 @default.
• W611330989 cites W1968558567 @default.
• W611330989 cites W1968601398 @default.
• W611330989 cites W1969184550 @default.
• W611330989 cites W1969592016 @default.
• W611330989 cites W1971863892 @default.
• W611330989 cites W1972584870 @default.
• W611330989 cites W1972860148 @default.
• W611330989 cites W1973099367 @default.
• W611330989 cites W1974643676 @default.
• W611330989 cites W1975399073 @default.
• W611330989 cites W1975807922 @default.
• W611330989 cites W1976583224 @default.
• W611330989 cites W1977807071 @default.
• W611330989 cites W1977861496 @default.
• W611330989 cites W1978912937 @default.
• W611330989 cites W1980010816 @default.
• W611330989 cites W1980438381 @default.
• W611330989 cites W1980490512 @default.
• W611330989 cites W1981061325 @default.
• W611330989 cites W1982015924 @default.
• W611330989 cites W1982086385 @default.
• W611330989 cites W1982815930 @default.
• W611330989 cites W1985071362 @default.
• W611330989 cites W1985151224 @default.
• W611330989 cites W1986790879 @default.
• W611330989 cites W1987560722 @default.

• next